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Green synthesis of metal nanoparticles is reputed to have a robust range of biomedical applications. Silver
nanoparticles (AgNPs) bio-fabricated using aqueous leaf extract of Annona muricata were characterized and
evaluated for in-vitro antioxidant, lipid peroxidation inhibition, anti-diabetic and antimicrobial activities as well as
cytotoxicity in human keratinocyte cells (HaCaT).
The extract induced colour change of silver salt solution which absorbed at 420 nm and confirmed the for-
mation of AgNPs. FTIR showed that free amide and hydroxyl groups were responsible for the synthesized
nanoparticles. Both XRD and SAED confirmed the crystalline nature of the particles with face centered cubic
(FCC) phase. The zeta potential revealed -27.2 mV potential and average distribution size of 35 nm. DLS indicated
that the majority of the particles were 86.78 nm size and with a polydispersity index (PDI) of 0.329.
AgNPs displayed strong activities against DPPH (IC50 ¼ 51.80 μg/ml), ABTS (IC50 ¼ 30.78 μg/ml), α-amylase
(IC50 ¼ 0.90 μg/ml) and α-glucosidase (IC50 ¼ 3.32 μg/ml). The particles exhibited a dose-dependent inhibition of
Fe2þ-induced lipid peroxidation with effective antimicrobial activity against a battery of bacterial strains and
cytotoxicity in HaCaT cell line. These findings revealed the potential biomedical applications of the particles and
further work will be required to establish its molecular mechanism of action.1. Introduction
The biological method of nanoparticle synthesis using plant extracts
is considered as eco-friendly and an excellent alternative for chemical
and physical methods [1]. While chemical and physical methods require
high energy and chemicals for the synthesis of nanoparticles, biological
agents make use of naturally occurring phytochemicals, proteins, and
enzymes for the formation and possible capping of the nanohybrids [2].
Synthesis of silver nanoparticles (AgNPs) using a biological method is
simple, reliable, nontoxic, and eco-friendly [3]. Green synthesized AgNPs
are biocompatible and safe for several therapeutic applications. The
broad biological activities of AgNPs led to its inclusion in householdBadmus).
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vier Ltd. This is an open access arproducts such as antimicrobial agents, textiles, wound dressing agents,
and antiseptic spray, to name a few [4].
The usefulness of the AgNPs found in drug delivery, diagnosis, and
extensively in disease treatment has led to a positive and unprecedented
growth in its study in the scientific sphere [1]. It has been found bene-
ficial as antibacterial, anti-diabetic, antioxidative and anti-proliferative
agents [5]. The plant biogenic-induced synthesis of nanoparticles is
considered essential due to its anti-cancer capability and lesser side ef-
fects and various other numerous positive effects in certain diseased
states [6]. Previous studies have related the anti-cancer properties of
AgNPs to be via the induction of oxidative stress and mitochondria and
DNA damage ultimately leading to apoptosis [7]. A number of com-October 2020
ticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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human ailments. Leaf extracts of plants such as Catharanthus roseus,
Rosmarinus officinalis, Camellia sinensis, Lantana camara have been used to
synthesize AgNPs with interesting potential biomedical applications [8,
9, 10, 11].
Annona muricata belongs to the family of Annonaceae found in trop-
ical and subtropical parts of the world. It is a tree with a height reaching
between 5-8 m and a diameter of 15–83 cm with an open roundish
canopy consisting of large glossy dark green leaves [12]. Different parts
of the plant are used as a cure for many illnesses in folklore treatment. It
is reportedly used against inflammation, diabetes, hypertension and
parasitic plague. The seed is used against worms and the fruits are used to
treat arthritis and fever [13]. The leaves are used against
hyper-glycaemia, inflammation, spasms and cancer [14]. Traditionally,
juice from the fruits and infusion of leaves and branches are used as a
sedative, against respiratory illness, malaria, gastrointestinal problems
and liver, heart and kidney problems. The plant is rich in secondary
metabolites such as saponins, alkaloids, flavonoids, terpenoids, annona-
ceous acetogenins, megastigmanes, cyclopeptides and essential oils [14].
These compounds inherent in this plant are known for the variety of
useful biomedical applications. Previous studies have used different parts
of the plant for the synthesis of AgNPs and confirmed that the plant
contains phytochemicals with the ability to synthesize and cap AgNPs
[15, 16].
Inspired by the important phytochemicals present in the plant
coupled with probable important biomedical applications, this is the first
synthesis of AgNPs from the plant leaves where no extraneous conditions
like high temperature and organic solvents were used. In addition, this
study report for the first time, the anti-diabetic, lipid peroxidation in-
hibitions and cytotoxic effect of the nanoparticles on an immortalized
human keratinocyte cell line (HaCaT).
2. Materials and methods
2.1. Chemicals and plant collection
All chemicals used were of analytical grade purchased from Sigma-
Merck (South Africa). Fresh leaves of Annona muricata were collected
fromOkeigbo in Ondo state, Nigeria and identified in the HerbariumUnit
of the Department of Pure and Applied Biology, Herbarium Unit, Ladoke
Akintola University of Technology, Ogbomoso, Nigeria.
2.2. Preparation of leaf extract
The leaves were air-dried under ambient environmental conditions
where after they were pulverized, using an electric blender to obtain a
fine powder. Leaf powder (6 g) was extracted in 100 ml Millipore water
using a magnetic stirrer for 2 h at 40 C. This was followed by cooling and
filtering using Whatman No1 filter paper to obtain the aqueous leaf
extract.
2.3. Silver nanoparticles synthesis
One milliliter of the aqueous leaf extract of Annona muricata was
added to 40 ml of 1 mM AgNO3 to synthesize silver nanoparticles with
continuous shaking in the presence of light for 30 min [17]. The colour
change to dark brown confirmed the formation of the silver nano-
particles. The particles were purified to separate any untreated reaction
mixtures by centrifugation at 10 000 rpm for 25 min and repeated
washing with deionized water.
2.4. Physicochemical characterization of AgNPs
UV-visible spectral analysis was used to monitor the bio-reduction of
the Ag salt solution of the aqueous extract of Annona muricata leaves. The
synthesis was monitored periodically by recording the absorbance2
spectral using a Polar Star Omega Microtitre Plate reader (BMG Labtech,
Ortenberg, Germany) at the wavelength ranging from 200 to 700 nm.
This was followed by subjecting the AgNPs to Fourier Transform Infrared
Spectroscopy (FTIR) to determine functional groups that contributed to
the synthesis at wavenumber ranging from 4000 cm1 to 400 cm1 using
the Thermo Scientific TM Nicolet. X-ray diffraction (XRD) nature was
carried on the particles to determine the crystal phase using the advanced
model Bruker AXS D8, operated at a voltage of 40 kV and a current of 30
mA with Cu, Kα radiation (λ- 1.54056 Å) in a Ɵ-2Ɵ configuration with
the range of 20–80o. TEM analysis was done on the TEM JEOL at 300 kV
to determine the size and shape of the silver nanoparticles from the TEM
micrograph. The elemental analysis of the nanoparticles was assessed
using Energy Dispersive X-Ray Spectroscopy (EDS). Dynamic light scat-
tering (DLS) of the nanoparticles was determined using a Malvern
Zetasizer Nanoseries (Nano-ZS90) to study the phase behaviour of the
particles.
2.5. Cell culture and maintenance
An immortallized keratinocyte cell line of adult human skin, HaCaT
was purchased from ATCC, (USA) and used for the study. The cells were
maintained in Dulbecco's Modified Eagles Medium (DMEM) containing
10% FBS and 1% PenStrep. The cells were kept at 37 C under the hu-
midified condition of 5% CO2 in air.
2.6. Antioxidant assays
2.6.1. DPPH (2, 2-diphenyl-1-picrylhydrazl) scavenging activity
The method of Kim et al. [18] with slight modification was followed
to evaluate DPPH scavenging potential of AgNPs. Different concentra-
tions of AgNPs and Trolox (standard) at 100 μl were added to 100 μl of
0.25 mMDPPH (dissolved in methanol) in 96-well plate and incubated at
room temperature for 30 min in the dark. The absorbance of the reaction
was recorded at 517 nm using a UV-Visible spectrophotometer (Multis-
kan, Thermo Scientific, USA).
2.6.2. ABTS (2, 20-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid))
scavenging activity
This assay followed the standard method as described by Moldovan
et al. [19] with slight modification. This involved the preparation of stock
solutions of 7.4 mM ABTS and 2.6 mM potassium persulfate. Next, 80 μl
of persulfate was added to 5 ml solution of ABTS and left in the dark for
12 h. A working solution was prepared by adding 2 ml of ABTS-persulfate
solution to 20 ml distilled water. Varying concentrations of AgNPs and
Trolox at 25 μl were added to 300 μl of the ABTS working solution. The
reacting mixture was incubated at room temperature in the dark for 30
min and read at 734 nm using a UV-visible spectrophotometer (Multis-
kan, Thermo Scientific, USA). The percentage scavenging ability was
calculated as stated in Eq. (1) below.
Percentage inhibition ¼ A blank  A sample
A blank
 100 equation (1
2.7. Inhibition of lipid peroxidation using egg yolk and S9 rat liver
homogenates
Inhibitions of Fe2þ-induced in vitro lipid peroxidation in egg yolk and
rat liver homogenates by AgNPs were carried out using the modified
methods of Badmus et al. [20]. AgNPs (500 μl) at various concentration
(350, 175, 87.5 and 43.75 μg/ml) was added to 500 μl of homogenate
(egg yolk or liver) (10%; v/v). Then, 50 μl of 0.07 mM ferrous sulphate
was added and the mixture was incubated at room temperature for 30
min. Briefly, thiobarbituric acid (1.5 ml) 0.8% in 1.1% SDS solution and
1.5 ml 10% acetic acid were added respectively. The mixture was mixed
on a vortex and heated at 95 C for 45 min to develop a pink colour. The
mixture was allowed to cool and then centrifuged at 5000 rpm for 5 min.
Figure 1. Green synthesis of silver nanoparticle using aqueous leaf extract of
A. muricata. The change of colourless solution of silver nitrate (A) to dark brown
solution (B) is an indication of bio-reduction of Agþ to AgNPs in the presence of
aqueous leaf extract of A. muricata under light ray for 30 min.
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water as blank and the percentage inhibition was calculated using the
formula as stated in Eq. (1).
2.8. In vitro anti-diabetic assay
2.8.1. α-Amylase inhibitory activity
The assay was evaluated by following the method described by
Madhusudhan and Kirankumar [21] with slight modification. The reac-
tion mixture in a 96-well plate contained 50 μl phosphate buffer (20 mM,
pH ¼ 6.9) with 6.7 mM sodium chloride, 20 μl α–amylase (2 U/ml), and
20 μl of varying concentrations of AgNPs and acarbose as standard. The
mixture was pre-incubated for 20 min at 37 C followed by the addition
of 20 μl of 1% soluble starch as substrate (20 mM phosphate buffer pH
6.9) with a further incubation for 30 min at 37 C. Briefly, 100 μl of 3,
5-dinitrosalicylic acid (DNS) was added and boiled for 10 min at 95 C
to stop the reaction. The absorbance was read at 540 nm using Multiplate
Reader (Multiskan Thermo Scientific, USA).
2.8.2. α-Glucosidase inhibition assay
The inhibition was assessed using the slightly modified method as
described by Madhusudhan and Kirankumar [21]. Each well of a 96-well
plate contained a reacting mixture of 50 μl phosphate buffer (100 mM,
pH ¼ 6. 8), 20 μl alpha-glucosidase (1 U/ml), and 20 μl of varying con-
centrations of AgNPs and acarbose as standard pre-incubated for 15 min
at 37 C. Further, 20 μl 4-Nitrophenyl β-D-glucopyranoside (P-NPG,
substrate) (5 mM) was added and followed by an incubation at 37 C for
20 min. The reaction was stopped by adding 50 μl Na2CO3 (0.1 M) and
the absorbance of p-nitrophenol released was read at 405 nm using a
multiplate reader (Multiskan, Thermo Scientific, USA). Furthermore, the
kinetic mechanism of the nanoparticle was evaluated using the IC50 value
concentration of the nanoparticles in the presence of graded concentra-
tion of the substrate. The reaction was evaluated using the same condi-
tion as stated above.
2.9. Bacterial growth inhibition assay
The antibacterial potency of the bio-fabricated AgNPs was evaluated
against certain clinical-relevant bacterial isolates, including Staphylo-
coccus aureus, Escherichia coli, Serratia marcescens, Bacillus cereus, Pseu-
domonas aeruginosa and Salmonella enterica using a microdilution assay
[20, 22]. An inoculum of each test bacterial strain was grown in nutrient
broth for 24 h and adjusted to 0.5 McFarland standard in 5.0 ml of
phosphate buffer (PBS). This was again diluted in 1:50 PBS to obtain a
1:20 in brain heart infusion broth (BHI) by adding 250 μl of (1:50) and
750 μl of BHI. For the test samples, 100 μL each of 100 and 50 μg/ml
concentrations of AgNPs was pre-mixed with 100 μL of BHI in a sterile
96-well microtitre plate. Thereafter, 100 μl of gradient concentrations of
the nanoparticles was inoculated with 100 μl of the test isolate. In the
control sample, the bacterial suspension (100 μl) was inoculated with
100 μl of sterile distilled water without the inclusion of AgNPs. The plates
were incubated with shaking at 37 C for 24 h. The plates were moni-
tored for clarity/turbidity and further supported with the addition of 40
μl of 0.2 mg/ml iodonitrotazolium chloride (INT) for colour change after
30 min incubation. Thereafter, the growth of bacterial isolates was
considered as optical density and read at a wavelength of 530 nm. All the
experiments were carried out in triplicate and the percentage growth
inhibition was calculated.
2.10. Cytotoxicity and viability assays
Cytotoxicity was evaluated using MTT [3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide] and the CytoTox Glo™ kit from
Promega. HaCaT cells were seeded in 96-well plates at a concentration of
2 104 cells per well. The cells were treated with varying concentrations
of the AgNPs while including tamoxifen and cisplatin (as positive3
controls) for 24 h. After treatment, 20 μl MTT (0.5 mg/ml) was added to
each well and allowed to further incubate in the CO2 incubator for 4 h.
Hereafter, the MTT containing medium in each well was discarded and
replaced with 100 μl DMSO to dissolve the blue formazan crystals where
after absorbance was read at 570 nm in a multi-well ELISA microplate
reader. The Cyto Tox Glo™ luminescent assay measures proteases that
leaked from compromised cell membranes of dead cells into the culture
media. The Manufacturer's protocol instruction was strictly adhered to
for the determination of the cell viability (Promega).
2.11. Statistical analysis
The results were analyzed using Two-Way ANOVA followed by post
hoc Tukey's multiple comparisons test using GraphPad Prism software
version 6.05 for Windows (GraphPad Software, La Jolla California USA
(www.graphpad.com). A P value of less than 0.05 was considered
significant.
3. Results and discussion
3.1. Photo aided synthesis of Annona muricata-AgNPs
Green bio-fabrication of AgNPs and its in vitro biological evaluation
was the major focus of this study. The change in colour from colourless to
dark brown after the addition of the aqueous leaf extract of A. muricata to
the silver salt solution, confirmed the reduction of Agþ to zero valent Ag
metal (Figure 1). Several earlier studies have reported dark brown colour
for the formation of silver nanoparticles [23, 24]. However, phenols,
alkaloids, flavonoids, terpenoids, and tannins have been previously re-
ported among the phytoconstituents present in the leaf of A. muricata
[25]. Some of these phytochemicals have been shown to be responsible
for the formation of nanoparticles by causing the excitation of surface
plasmon resonance (SPR) of the particles [26, 27, 28]. Photo induced
synthesis of the AgNPs as presented in this study has shown that intro-
duction of heat is not necessary as reported by previous studies [15, 29].
3.2. Physicochemical characterization of synthesized AgNPs
The UV-visible spectral SPR peak of AgNPs was detected at about 420
nm, a typical absorbance band of silver nanoparticles as presented in
Figure 2 [11,30]. To further understand the specific chemical
Figure 3. FTIR spectral of powdered (a) leaf of A muricata and (b)
A. muricata-AgNPs.
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the reduction and stabilization of the nanoparticles, the FTIR spectros-
copy was employed. The FTIR analysis was carried out on both the
extract and the dried pellets of the AgNPs. Apparent changes in the
spectra of the leaf extract and synthesized AgNPs were observed
(Figure 3). The FTIR spectrum of the leaf extract (Figure 3a) showed
bands at 428, 1017, 1436, 1619, 2919, and 3212 cm1. The peak posi-
tioned at 1017 cm1 relates to vibration from a single bond between
carbon and nitrogen (C–N) that can be assigned to aliphatic amines. This
assignment was corroborated by the two weak bands at 1436 and 1619
cm1, both of which are assignable to proteins. The 2916 cm1 band
further confirms the presence of nitrogen-containing functional groups. A
more pronounced band, however, appeared at about 3212 cm1, signi-
fying the presence of hydroxyl functional groups that may belong to
polyphenols in general as earlier mentioned. Hence, it can be inferred
that polyphenols such as phenols and flavonoids may participate in the
reduction process that led to the successful bio-fabrication of the particles
that were capped with nitrogen-bearing molecules such as amines or
proteins. Similarly, the FTIR spectrum of the silver nanoparticles
(Figure 3b) biosynthesized from the aqueous leaf extract shows some
common functional groups with enhanced intensity. The band at 1641
and 3296 cm1 can be ascribed to some free amide I and hydroxyl groups
of phytochemicals present [31]. The 1619 and 1641 cm1 bands in both
leaf extract and the AgNPs further confirm that the structure of proteins
was not altered after reduction [32]. This further buttress the fact that
proteins and various polyphenols served as bioreductants from the
extract and equally responsible for stabilizing the bio-fabricated AgNPs.
A previous study indicated the involvement of alcohol amines for the
synthesis of silver nanoparticles from Streptomyces sp [33]. The FITR
peaks obtained in this study are closely related to the observed peaks in
earlier studies using the leaf and fruit extracts of A. muricata [15, 16, 34].
This confirms that similar phytochemicals are responsible for the syn-
thesis of the AgNPs by the plant irrespective of the mode of synthesis.
The crystal structure of the biosynthesized AgNPs was examined with
the aid of an X-ray Diffractometer. Based on the XRD pattern (Figures 4a
and 4b), it shows that the AgNPs were in polycrystalline form. The two
theta degrees were approximately 38, 44, 64, and 78 which correspond
well with the planes (111, 200, 220, and 311 respectively) of pure
crystalline silver [35]. In addition to the XRD result, selected area elec-
tron diffraction (SAED) assessment further confirms the crystal nature of
the AgNPs. The bright rings in the SAED agree with the planes when the
diameters of the rings are considered (Figure 4b).
Figures 5a and b show the TEMmicrographs accompanied by particle
size distribution (Figure 5c) of the AgNPs. The mean diameter of the
AgNPs was found to be approximately 35 nm. Most of the seeds were in
the spherical forms as can be observed in Figure 5 which, further shows
that both AgNPs were monodispersed with a spherical shape. The sizes ofFigure 2. UV-visible spectrum of synthesized AgNPs using aqueous leaf extract
of A. muricata at 420 nm.
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the synthesized AgNPs using various plants in previous studies have been
found to be in the range of 20–53 nm [15, 16, 34]. In addition, as shown
in Figure 4b, jellylike substances can be seen surrounding the particles.
This may be related to biomolecules serving as the stabilizing agents to
the fabricated AgNPs. To further confirm the formation of AgNPs, the
EDS was employed. The EDS spectrum in Figure 6 shows an arrow
pointing to the region where clusters of silver atoms were detected by the
analysis. Previously, the presence of silver atoms has been shown to
imply the confirmation of the successful fabrication of AgNPs [36]. The
EDS also shows the presence of other elements like carbon from the
phytochemicals in the precursor plant extract and copper from the copper
grid used in the sample preparation for TEM [37]. The size distribution,
shape, assembly, stability and aggregation of nanoparticles depend on
the nature of preparation and reducing/capping agents [38]. Phase
behaviour of nanoparticles is, among other important factors used to
evaluate the propriety of the particles before applications. Interestingly,
light scattering is a special technique that gives an idea of the hydrody-
namic size of the particles. Through DLS measurement, the electric
charge around the surface of nanoparticles is also understood [39]. DLS
measurement of the particles indicated that the majority of the particles
are of 86.78 nm size with a polydispersity index (PDI) of 0.329. The PDI
measures the degree of non-uniformity of size distribution of particles,
which is the ratio of weight average and the number average molecular
weight. The normal range of PDI is between 0.05-0.7 while the value
beyond 0.7 indicates undesirable broad particle size distribution [40].
The zeta potential value of -27.2 mv (Figure 7) means that a large
negative ion exists on the surface of the particles. It further implies that a
strong repulsive force is present in the assembly of ions because of the
high negative zeta potential. The strong repulsive force, however, re-
duces the possibility of aggregation and enhances the stability of nano-
particles [41]. The aggregation in synthesized nanoparticles induces
instability in the particles and hence obliterates its essential functional
properties [42]. The DLS, PDI and zeta potential values of the work of
Meenakshisundaram et al. [29] and Gavamukulya et al. [16] are different
from the values obtained in this study. The disparity in values is likely to
be due to the differences in the preparation of the nanoparticles.3.3. Antioxidant activities of synthesized AgNPs
The in vitro free radical scavenging ability of the AgNPs was evaluated
using DPPH and ABTSþ radicals, respectively. The assays are common
endpoint methods of determining the antioxidant capacity of various
compounds. DPPH is a stable radical that readily accepts hydrogen or an
electron from the antioxidant agent that bleaches purple to a golden
yellow colour. The synthesized AgNPs effectively scavenged DPPH in a
Figure 4. XRD (a) and SAED (b) profiles of A. muricata-AgNPs.
Figure 5. TEM images (a, b) depicted the size and shape of the synthesized aqueous A. muricata leaf extract-induced AgNPs.
Figure 6. EDS of aqueous A. muricata leaf extract-induced AgNPs showing the
elemental composition.
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Trolox with 5.25 μg/ml (Table 1). The nanoparticles scavenged the ABTS
radical with IC50 value of 30.78 μg/ml as presented in Table 1. The lower
IC50 value against ABTS comparatively to DPPH implies that the AgNPs is
a stronger scavenger of ABTS radical. The antioxidant property of the
nanoparticles was borne out of the interaction of antioxidant agents in
the aqueous leaf extract that may be involved in the bio-reduction and
subsequent capping of the silver salt. These phytochemicals are proposed
to have conferred the antioxidant property onto the bio-fabricated
nanoparticles. Antioxidants are important molecules needed to coun-
teract the induction of excessive free radicals in an aerobic organism and5
consequently protect against induced oxidative stress-related ailments
[43]. Previous studies have reported the ability of AgNPs fabricated using
leaf extracts prepared from C. roseus and P. granatum as good scavengers
of free radicals [8, 44]. Antioxidant property of nanoparticles has been
reported to have a comparative advantage over the traditional antioxi-
dant delivery system such as encapsulated protection of antioxidant
agent, elevated bioavailability, targeted and controlled delivery [45].
3.4. Lipid peroxidation inhibitory activity of synthesized AgNPs
Lipid peroxidation is the product of radicals’ assault on the lipid
membrane with far-reaching implications on the functionality of the
cells. The cell functions are impaired due to the disruption of the cell
membrane assembly leading to prejudiced membrane fluidity, perme-
ability, ion transport modification, and eventual inhibition of metabolic
processes [46, 47]. The TBARS assay is a commonly used method of
determination of lipid peroxidation through spectrophotometric evalu-
ation of TBARS-MDA adducts [20]. The silver nanoparticles show
dose-dependent inhibition of Fe2þ-induced lipid peroxidation in both
liver S9- and chicken egg yolk homogenates (Table 2). Each level of
concentration of the particles displays a better/higher protection against
the induced lipid peroxidation when using the egg yolk as compared to
the liver homogenate results. This result shows that the antioxidant
components and enzymes inherent in the liver homogenate did not boost
the activity of the nanoparticles against induced lipid peroxidation. In
addition, the nanoparticles protect the egg yolk from peroxidation
Figure 7. Dynamic light scattering measurement showing (a) the average hydrodynamic size (HDS) of 84.17 nm and a polydisperity index (PDI) of 0.329 and (b)
showing the zeta potential value of -27.2 mV.
Table 1. In vitro Antioxidant (DPPH and ABTS), Antidiabetic (α-amylase and α-glucosidase) and cytotoxicity potential of aqueous A. muricata leaf extract-induced
AgNPs.
IC50 (μg/ml) DPPH ABTS α-amylase α-glucosidase Cytotoxicity
AgNPs 51.80  3.14 30.78  1.10 0.90  0.01*** 3.32  0.32*** 57.37  3.66
Trolox 5.26  0.04*** 3.74  0.01***
carbose 10.20  0.05 610.65  4.27
Cisplatin 3.12  0.54***
Tamoxifen 22.00  1.02***
The results are expressed as mean  SD of three different independent experiments (n ¼ 3). The results with superscript *** indicate significantly difference at P <
0.0001. Trolox, acarbose, cisplatin and tamoxifen are standards used for different experiments.
Table 2. Inhibition of Fe2þ-induced lipid peroxidation in egg yolk and rat liver





350.0 66.37  1.22 61.13  0.20
175.0 58.29  0.59 47.97  0.52
87.5 48.67  1.60 40.16  0.23
43.8 45.58  4.51 39.36  0.31
The results are expressed as mean  SD of three different independent experi-
ments (n ¼ 3).
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polyunsaturated lipids in egg yolk with low components of antioxidant
booster when compared with the liver [20].3.5. In vitro antidiabetic potential of synthesized AgNPs
Alpha-amylase and Alpha-glucosidase inhibitors are agents that can
be used to effectively control postprandial hyperglycemia-linked Type II
diabetes mellitus [48]. The silver nanoparticles significantly (P <
0.0001) inhibited both α-amylase and α-glucosidase with IC50 values of
0.90 and 3.32 μg/ml, respectively, when compared with the standard,
acarbose with IC50 values of 10.20 and 610.65 μg/ml respectively
(Table 1). The biosynthesized AgNPs was significantly potent against
both enzymes when compared with the standard acarbose. Several
studies have reported the anti-diabetic activity of AgNPs using the
inhibitory activities against the two enzymes. However, to the best of our
knowledge, none of the reported activities have been as strong as what is6
being reported in this study [44, 49, 50]. This result implies that
A. muricata-AgNPs as prepared in this study could be a strong
anti-diabetic entity for the future development of a safe and physiolog-
ically functional drug. Furthermore, the alpha-glucosidase inhibitory
kinetic study shows that the particles inhibited the enzyme through
non-competitive inhibition (Figure 8). This implies that the particles
inhibited the enzyme by binding to the other site of the enzyme apart
from the active site and enzyme-substrate complex. In addition, the
particles have a strong affinity to the other site of the enzyme apart from
the active site and do not interfere with substrate binding but prevent
catalytic step. The synthesis of eco-friendly nanoparticles has become
effective and emerging treatment of diabetes mellitus and its associated
legacy and complication [51].3.6. Antimicrobial activities of synthesized AgNPs
The AgNPs inhibited the growth of bacterial isolates at both con-
centrations of 100 and 50 μg/ml. The maximal inhibition was achieved
for all the isolates at 100 μg/ml. S. aureus was the most sensitive to the
nanoparticles with 61.29% inhibition followed by S. marcescens and P.
aeruginosa with 59.34 and 54.42% inhibition respectively at 50 μg/ml.
The least sensitive to the AgNPs at 50 μg/ml were B. cereus and Salmonella
sp with 26.21 and 21.44% inhibition (Figure 9). Silver nanoparticles
have been reported to display strong antibacterial property against both
Gram positive and negative bacteria. Silver nanoparticles synthesized
using Punica granatum, Prosopis cineraria leaf, Ananas comosus peel
extract, Rosmarinus officinalis leaf and Cocoa pod husk extract have been
reported to exhibit considerable antibacterial activities in agreement
with the present study [5, 6, 9, 44, 52]. However, several mechanisms
have been attributed to the antibacterial effect of AgNPs. These mecha-
nisms include, but are not limited to the attachment to and disruption of
Figure 8. Kinetic inhibition of α-glucosidase by aqueous A. muricata leaf
extract-induced AgNPs.
Figure 9. Antimicrobial potential of aqueous A. muricata leaf extract-induced
AgNPs using microdilution assay. Each bar represents mean  SD of triplicate
experiments. Bar not sharing a common alphabet (a–c) are significantly different
(P < 0.05).
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replication, induced ROS, derangement of the glycolytic pathway and
modulation of cellular signaling by dephosphorylating putative key
peptide substrates on tyrosine residues [6, 8, 53].
3.7. Cytotoxicity potential of synthesized AgNPs
The MTT assay and CytoTox Glo™ kit (Promega) were used to
determine the cytotoxicity and the viability potential of the synthesizedFigure 10. Effect of aqueous A. muricata leaf-induced AgNPs on HaCaT cell
viability (ATP expressing cells) using CytoTox™ kit from Promega. Each bar
represents mean  SD of three different independent experiments and ***P <
0.0001 shows level of significance.
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nanoparticles compared to standard anti-cancer drugs, tamoxifen and
cisplatin against the HaCaT cell line, respectively. The two assays results
revealed the in vitro cytotoxicity ability of the nanoparticles against the
HaCaT cell line. The IC50 cytotoxicity value of the nanoparticles was
found to be 57.37 μg/ml compared to that of cisplatin (3.12 μg/ml) and
tamoxifen (22.00 μg/ml) as presented in Table 1 and Figure 10. Previous
similar studies have shown the cytotoxicity effect of AgNPs in different
cell lines [5, 6, 39]. The cytotoxicity of AgNPs has been related to the
active interaction between the phytoconstituents and the silver atoms
with functional groups of intracellular proteins, nitrogen bases and
phosphate groups in the DNA [6]. In addition, AgNPs cytotoxic effect can
also be ascribed to cellular damage, induction of a cascade of immuno-
logical effects and electrostatic attraction between the cell and AgNPs
[54]. Generation of reactive oxygen species (ROS) leading to the induc-
tion of oxidative stress linked release of pro-inflammatory protease,
caspase induction and eventual cell death through apoptosis is another
mechanism of nanoparticles induced cytotoxicity [55]. Furthermore, the
AgNPs did not induce caspase-3 enzyme (result not shown), the final
executioner enzyme for the induction of apoptosis. This is contrary to the
previous finding that reported activation of apoptosis of the nano-
particles in NSCLC cell lines using different assay apart from the
caspase-3 induction [29]. This implies either that the cells had already
gone beyond apoptosis stage at the period of evaluation or the HaCaT cell
line is not sensitive to the apoptotic effect induced by the nanoparticles.
4. Conclusion
The synthesized AgNPs using the leaf extract of A. muricata showed
strong in vitro antioxidant activity, lipid peroxidation inhibition, effective
in vitro anti-diabetic and antimicrobial activities as well as cytotoxicity
against the HaCaT cell line. These arrays of unique medicinal bio-active
potential can position the AgNPs as an agent for future biomedical
application, most especially as an anti-diabetic agent where its activity
was most pronounced. Future in vivo studies would further establish the
possibility of its biomedical exploitation.
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